Tag - PharmaJet

Developments

PharmaJet partners with Abnova to develop needle-free COVID-19 vaccine

Closely-held PharmaJet’s needle-free injection system will be used to deliver a SARS-CoV mRNA vaccine being developed by Abnova, the world’s largest antibody vaccine manufacturer. “Our system has been found to improve...

May 19, 2020

Executive Moves

PharmaJet appoints Chris Cappello as president and CEO

Chris Cappello Closely-held PharmaJet appointed Chris Cappello as its president and CEO, replacing Ron Lowy, who was appointed as executive chairman. “In the 10 years that [Mr.Cappello] has worked for PharmaJet, he has...

April 28, 2020

Feature

PharmaJet injection devices creating needle-free world

By Len Zehr Closely-held PharmaJet’s needle-free injection devices have the potential to rapidly improve the delivery of vaccines in emerging markets as well as pharmaceuticals currently under development. “We are at...

February 26, 2019

Developments

Adamas Finance subscribes for $5-million of PharmaJet bonds

Adamas Finance Asia intends to subscribe for up to $5-million in a convertible bond offering by closely-held PharmaJet, the maker of needle-free injection devices. The PharmaJet injectors have received FDA approval, CE...

January 17, 2019

Developments

PharmaJet, Mundipharma team up to boost access to needle-free drug technology

PharmaJet and Mundipharma have inked an exclusive partnership to market and distribute PharmaJet’s Tropis and Stratis needle-free drug-delivery devices to more than 120 markets around the world. The devices are designed...

July 26, 2018

Tag - PharmaJet

PharmaJet partners with Abnova to develop needle-free COVID-19 vaccine

PharmaJet appoints Chris Cappello as president and CEO

PharmaJet injection devices creating needle-free world

Adamas Finance subscribes for $5-million of PharmaJet bonds

PharmaJet, Mundipharma team up to boost access to needle-free drug technology

Subscribe